Molecular Devices Purchase to Transform MDS Sciex

/0 Comments/in , /by

Sunnyvale, CA and Toronto, Canada 1/29/07—MDS has signed a definitive agreement to purchase Molecular Devices for $615 million in cash, or $35.50 per share, a 49% premium over the January 26 trading price. In the first 12 months, the acquisition is expected to add $190 million in revenues and $45–$50 million in EBITDA (earnings before […]

Read more →

Private Equity Firm Acquires UVP

/0 Comments/in , , /by

Upland, CA 1/11/07—UVP, a suppler of laboratory imaging systems, was acquired by private equity investment firm Carlisle Enterprises on January 2. “Carlisle’s access to capital markets, their industry knowledge and their operating expertise represent significant support for UVP’s continued growth and development,” stated Leighton Smith, president and CEO of UVP. Carlisle’s previous laboratory-related investments include […]

Read more →

VWR Adds GE Healthcare Bio-Science Products

/0 Comments/in /by

West Chester, PA, 1/24/07—VWR International has entered into a definitive agreement to distribute select product lines of GE Healthcare Bio-Sciences in North America, effective January 26. GE products to be offered include radiochemicals, film and certain electrophoresis, chromatography and nucleic acid purification products. “In many cases, the convenience VWR adds through logistics and access to […]

Read more →

Microarrays

/0 Comments/in , , , , /by

Company Announcements NimbleGen Systems named Gregory McGuinness as vice president of International Business. He was previously director of European Business Development for Gene Logic. NimbleGen Systems obtained a license to the “Southern array patents” from Oxford Gene Technology (OGT) and will supply OGT with microarrays for use in its service business. Oxford Gene Technology granted […]

Read more →